PURPOSE: Transcatheter aortic valve implantation (TAVI) techniques show favourable survival outcomes in high-risk patients, but the incidence of postoperative delirium is unknown. We conducted a historical cohort study to compare postoperative delirium in retrograde transfemoral (TF) versus anterograde transapical (TA) TAVI procedures. We also sought to identify independent predictors of delirium following TAVI. METHODS: We performed a retrospective chart review on all patients who underwent TF (n = 77) or TA (n = 45) TAVI during 2008 and 2009 at St. Paul's Hospital (Vancouver, BC, Canada), the pioneering centre for these procedures. The primary outcome was a documented physician diagnosis of delirium. Abstracted data included information on demographics, medical history, surgical procedure, anesthesia, and postoperative care. We employed a multivariable logistic regression to identify independent predictors of delirium. RESULTS: Delirium occurred in 12% of TF patients vs 53% of TA patients (P < 0.001). Preoperatively, the groups differed significantly in the rates of hypertension, pulmonary hypertension, dyslipidemia, peripheral vascular disease, congestive heart failure, previous myocardial infarction, and memory impairment. Differences in anesthetic management were also observed between the TF vs TA groups regarding inhalational anesthetics, opioids, neuromuscular blockers, antihemorrhagic drugs, and antibiotics. Independent predictors for delirium after TAVI included coronary artery disease (odds ratio [OR] 12.7; 95% confidence interval [CI] 1.0 to 154.9), cognitive impairment (OR 6.5; 95% CI 1.8 to 23.2), and cardiac arrhythmia (OR 3.5; 95% CI 1.1 to 11.6). Compared to the TF approach, TA-TAVI independently increased the risk of delirium (OR 13.8; 95% CI 3.3 to 59.0). CONCLUSIONS: Patients undergoing TA-TAVI had a markedly increased incidence of postoperative delirium compared with patients undergoing TF-TAVI.
PURPOSE: Transcatheter aortic valve implantation (TAVI) techniques show favourable survival outcomes in high-risk patients, but the incidence of postoperative delirium is unknown. We conducted a historical cohort study to compare postoperative delirium in retrograde transfemoral (TF) versus anterograde transapical (TA) TAVI procedures. We also sought to identify independent predictors of delirium following TAVI. METHODS: We performed a retrospective chart review on all patients who underwent TF (n = 77) or TA (n = 45) TAVI during 2008 and 2009 at St. Paul's Hospital (Vancouver, BC, Canada), the pioneering centre for these procedures. The primary outcome was a documented physician diagnosis of delirium. Abstracted data included information on demographics, medical history, surgical procedure, anesthesia, and postoperative care. We employed a multivariable logistic regression to identify independent predictors of delirium. RESULTS:Delirium occurred in 12% of TF patients vs 53% of TA patients (P < 0.001). Preoperatively, the groups differed significantly in the rates of hypertension, pulmonary hypertension, dyslipidemia, peripheral vascular disease, congestive heart failure, previous myocardial infarction, and memory impairment. Differences in anesthetic management were also observed between the TF vs TA groups regarding inhalational anesthetics, opioids, neuromuscular blockers, antihemorrhagic drugs, and antibiotics. Independent predictors for delirium after TAVI included coronary artery disease (odds ratio [OR] 12.7; 95% confidence interval [CI] 1.0 to 154.9), cognitive impairment (OR 6.5; 95% CI 1.8 to 23.2), and cardiac arrhythmia (OR 3.5; 95% CI 1.1 to 11.6). Compared to the TF approach, TA-TAVI independently increased the risk of delirium (OR 13.8; 95% CI 3.3 to 59.0). CONCLUSIONS:Patients undergoing TA-TAVI had a markedly increased incidence of postoperative delirium compared with patients undergoing TF-TAVI.
Authors: Peter Stachon; Klaus Kaier; Andreas Zirlik; Jochen Reinöhl; Timo Heidt; Wolfgang Bothe; Philip Hehn; Manfred Zehender; Christoph Bode; Constantin von Zur Mühlen Journal: Clin Res Cardiol Date: 2018-04-13 Impact factor: 5.460
Authors: A S Boureau; J N Trochu; A Rouaud; R Hureau; P Jaafar; T Manigold; V Letocart; P Guerin; G Berrut; L de Decker Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Hersh S Maniar; Brian R Lindman; Krisztina Escallier; Michael Avidan; Eric Novak; Spencer J Melby; Marci S Damiano; John Lasala; Nishath Quader; Ravinder Singh Rao; Jennifer Lawton; Marc R Moon; Daniel Helsten; Michael K Pasque; Ralph J Damiano; Alan Zajarias Journal: J Thorac Cardiovasc Surg Date: 2015-11-11 Impact factor: 5.209
Authors: Maisha M Khan; Krista L Lanctôt; Stephen E Fremes; Harindra C Wijeysundera; Sam Radhakrishnan; Damien Gallagher; Dov Gandell; Megan C Brenkel; Elias L Hazan; Natalia G Docteur; Nathan Herrmann Journal: Clin Interv Aging Date: 2019-05-08 Impact factor: 4.458
Authors: Alexander Maier; Benedikt Hammerich; Frank Humburger; Thomas Brieschal; Timo Heidt; Wolfgang Bothe; Holger Schröfel; Klaus Kaier; Manfred Zehender; Jochen Reinöhl; Christoph Bode; Constantin von Zur Mühlen; Peter Stachon Journal: PLoS One Date: 2020-02-05 Impact factor: 3.240
Authors: Kees van der Wulp; Marleen van Wely; Lars van Heijningen; Bram van Bakel; Yvonne Schoon; Michel Verkroost; Helmut Gehlmann; Leen Van Garsse; Priya Vart; Peter Kievit; Marcel Olde Rikkert; Wim Morshuis; Niels van Royen Journal: J Am Geriatr Soc Date: 2019-07-25 Impact factor: 5.562
Authors: Erica Tilley; Peter J Psaltis; Tobias Loetscher; Daniel H Davis; Stephanie L Harrison; Susan Kim; Hannah A D Keage Journal: Am J Cardiol Date: 2018-09-08 Impact factor: 2.778